Fate Therapeutics FATE
NASDAQ FATE
$2.30 -0.07 (-2.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Non-Current Deffered Revenue (2015 - 2022)

Updated

Fate Therapeutics (FATE) reported Non-Current Deffered Revenue of $12.41 million for Q3 2022, down 61.9% from $32.56 million a year earlier and down 30.1% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Non-Current Deffered Revenue (2015 - 2022) Analysis & Trends

At the end of FY2021, Fate Therapeutics posted Non-Current Deffered Revenue of $27.12 million, down 41.1% from FY2020.

  • Non-Current Deffered Revenue has a five-year compound annual growth rate of 57.2% (FY2016 to FY2021).
  • By year, Non-Current Deffered Revenue came in at $46.02 million in FY2020, $3.78 million in FY2019 (-49.7%), $7.5 million in FY2018 (+935.9%) and $724,000 in FY2017 (-74.4%).
  • The Q3 2022 figure ranks as the lowest quarterly Non-Current Deffered Revenue since Q1 2020.
  • Year over year, Non-Current Deffered Revenue has now declined in each of the last six quarters, with an average decline of 44.6% over the last six quarters.
  • The high point for year-over-year Non-Current Deffered Revenue in five years was Q3 2020 (growth of 998.3%); the low point was Q1 2018 (a decline of 91.4%).
  • Per Business Quant data, the three quarters before Q3 2022 came in at $17.74 million (Q2 2022), $22.53 million (Q1 2022) and $27.12 million (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Fate Therapeutics 276.57 Mn 276.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 12.41 Mn
Jun 30, 2022 17.74 Mn
Mar 31, 2022 22.53 Mn
Dec 31, 2021 27.12 Mn
Sep 30, 2021 32.56 Mn
Jun 30, 2021 38.93 Mn
Mar 31, 2021 43.03 Mn
Dec 31, 2020 46.02 Mn
Sep 30, 2020 49.38 Mn
Jun 30, 2020 54.69 Mn
Mar 31, 2020 3.12 Mn
Dec 31, 2019 3.78 Mn
Sep 30, 2019 4.50 Mn
Jun 30, 2019 5.24 Mn
Mar 31, 2019 6.38 Mn
Dec 31, 2018 7.50 Mn
Sep 30, 2018 8.00 Mn
Mar 31, 2018 198,000.00
Dec 31, 2017 724,000.00
Sep 30, 2017 1.25 Mn
API Access

Fate Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=FATE&period=max&api_key=YOUR_API_KEY